Page h 1
, Roach’s hIntroductory hClinical hPharmacology h11th
hEditionhTest hBank
1. A hnursing hinstructor his hpreparing ha hteaching hplan hfor ha hgroup hof hnursing
hstudents habout hpharmacology. hWhen hdescribing hthis htopic, hthe hinstructor hwould
hfocus hthe hdiscussion honhwhich hof hthe hfollowing has han hessential haspect?
A) Drug hname
B) Drug hclass
C) Drug haction
D) Drug
hsourcehAns: h C
hFeedback:
Pharmacology his hthe hstudy hof hdrugs hand htheir haction hon hliving horganisms.
hThus, han hessential haspect hof hpharmacology his hdrug haction. hAn hunderstanding
hof hthe hdrug hname,hdrug hclass, hand hdrug hsource his himportant, hbut hthe hmost
hcritical haspect hrelated hto hpharmacology his hhow hthe hdrug hacts hin hthe hbody.
2. A hnursing hstudent his hpreparing hto hadminister ha hprescribed hdrug hto ha hpatient. hThe
hstudent hreviews hinformation habout hthe hdrug hand hits hactions. hWhich hof hthe
hfollowing hwould hbe hthehbest hchoice hfor hobtaining hthis hinformation? hSelect hall hthat
happly.
A) Nursing hinstructor
B) Nurse hassigned hto hthe hpatient
C) Clinical hdrug hreference
D) Prescribing hhealth hcare hprovider
E) Clinical
hpharmacisthAns: h C, hE
Feedback:
Although hthe hnursing hstudent hcan hask hthe hnursing hinstructor, hthe hnurse hassigned
hto hthe hpatient, hand hthe hprescribing hhealth hcare hprovider hfor hinformation habout
hthe hdrug, hthe hbesthchoices hfor hdrug hinformation hwould hinclude han happropriate
hdrug hreference hand hthe hclinical hpharmacist.
3. When hdescribing hthe hvarious htypes hof hmedications hto ha hgroup hof hnursing
hstudents, hahnursing hinstructor hwould hidentify hwhich hof hthe hfollowing has ha
hsource hfor hderiving hmedications? hSelect hall hthat happly.
A) Plants
B) Synthetic hsources
C) Mold
D) Minerals
E) Animals
hAns: hA, hB, hC,
hD, hEhFeedback:
Medications hare hderived hfrom hnatural hsources, hfor hexample, hplants, hmolds,
hminerals, handhanimals, has hwell has hcreated hsynthetically hin ha hlaboratory.
Page h 2
,4. Which hof hthe hfollowing hnames hmay hbe hassigned hto ha hdrug hduring hthe
hprocess hofhdevelopment? hSelect hall hthat happly.
A) Chemical hname
B) Official hname
C) Pharmacologic hname
D) Trade hname
E) Nonproprietary
hnamehAns: h A, hB, hD, hE
hFeedback:
Throughout hthe hprocess hof hdevelopment, hdrugs hmay hhave hseveral hnames hassigned
hto hthem hincluding ha hchemical hname, ha hgeneric h(nonproprietary) hname, han hofficial
hname, handha htrade hor hbrand hname.
5. A hdrug hmay hbe hclassified hby hwhich hof hthe hfollowing? hSelect hall hthat happly.
A) The hchemical htype hof hthe hdrug's hactive hingredient
B) The hway hthe hdrug his hused hto htreat ha hspecific hcondition
C) The hgeneric hname hof hthe hdrug
D) The htrade hname hof hthe hdrug
E) The hnonproprietary hname hof hthe
hdrughAns: h A, hB
Feedback:
A hdrug hmay hbe hclassified hby hthe hchemical htype hof hthe hactive hingredient hor hby hthe
hway hit hishused hto htreat ha hparticular hcondition. hGeneric, htrade, hand hnonproprietary
hrefer hto hhow ha hdrug his hnamed.
6. A hgroup hof hnursing hstudents hare hreviewing hinformation habout hthe hprocess hof
hdrug hdevelopment hin hthe hUnited hStates. hThe hstudents hdemonstrate
hunderstanding hof hthis hprocess hwhen hthey hidentify hthat hwhich hof hthe hfollowing
hcategories hare hassigned hby hthehFood hand hDrug hAdministration hto hnewly
happroved hdrugs? hSelect hall hthat happly.
A) Metabolite
B) Noncontrolled hsubstance
C) Prescription
D) Nonprescription
E) Controlled
hsubstancehAns: h C, hD, hE
Feedback:
Once hdrugs hare happroved hfor huse, hthe hFDA hassigns hthe hdrug hto hone hof hthe
hfollowing hcategories: hprescription, hnonprescription, hor hcontrolled hsubstance.
hMetabolite hrefers htohthe hinactive hform hof hthe hdrug. hNoncontrolled hsubstance his
ha hterm hthat his hnot hused.
Page h 3
, 7. Which hof hthe hfollowing hwould hbe hmost himportant hfor hthe hnurse hto hdo hto
hensure hthe hsafehuse hof hprescription hdrugs hin hthe hinstitutional hsetting? hSelect hall
hthat happly.
A) Administering hdrugs
B) Monitoring hclients hfor hdrug heffects
C) Prescribing hdrugs
D) Evaluating hclients hfor htoxic heffects
E) Educating hclients/caregivers habout
hdrugshAns: h A, hB, hD, hE
Feedback:
In hthe hinstitutional hsetting, hthe hnurse's hrole hto hensure hsafe huse hof hprescription
hdrugs hincludes hadministering hdrugs, hmonitoring hdrug heffects, hevaluating hfor htoxic
heffects, handheducating hclients hand hcaregivers habout hdrugs.
8. The hnurse his hhelping ha hclient hreview ha hprescription hfrom hthe hhealth hcare
hprovider. hWhenhexamining hthe hprescription, hwhich hof hthe hfollowing hwould hthe
hnurse hexpect hto hfind hdocumented? hSelect hall hthat happly.
A) Name hof hthe hdrug
B) Dosage hof hthe hdrug
C) Route hof hdrug hadministration
D) Times hof hdrug hadministration
E) Licensed hprescriber's
hsignaturehAns: h A, hB, hC, hD, hE
Feedback:
The hprescription hmust hcontain hthe hclient's hname, hthe hname hof hthe hdrug, hthe
hdosage, hthehmethod hand htimes hof hadministration, hand hthe hsignature hof hthe
hlicensed hhealth hcare hprovider hprescribing hthe hdrug.
9. After hteaching ha hgroup hof hnursing hstudents habout hnonprescription hdrugs, hthe
hnursing hinstructor hdetermines hthat hthe hteaching hwas hsuccessful hwhen hthe hstudents
hidentify hwhichhof hthe hfollowing? hSelect hall hthat happly.
A) They hrequire ha hlicensed hhealth hcare hprovider's hsignature.
B) They hare hreferred hto has hover-the-counter hdrugs.
C) They hcan hbe htaken hwithout hrisk hto hthe hclient.
D) They hhave hcertain hlabeling hrequirements.
E) They hshould hbe htaken honly has hdirected hon hthe
hlabel.hAns: h B, hD, hE
Feedback:
Nonprescription hdrugs hare hoften hreferred hto has hover-the-counter h(OTC) hdrugs.
hThey hdo hnot hrequire ha hprescription h(a hlicensed hhealth hcare hprovider's hsignature)
hbut hdo hnot hcome hwithout hrisk hto hthe hclient. hThe hfederal hgovernment hhas
himposed hlabeling hrequirements hofhOTC hdrugs hand hthey hshould honly hbe htaken has
hdirected hon hthe hlabel hunless hunder hthe hsupervision hof ha hhealth hcare hprovider.
Page h 4
, Roach’s hIntroductory hClinical hPharmacology h11th
hEditionhTest hBank
1. A hnursing hinstructor his hpreparing ha hteaching hplan hfor ha hgroup hof hnursing
hstudents habout hpharmacology. hWhen hdescribing hthis htopic, hthe hinstructor hwould
hfocus hthe hdiscussion honhwhich hof hthe hfollowing has han hessential haspect?
A) Drug hname
B) Drug hclass
C) Drug haction
D) Drug
hsourcehAns: h C
hFeedback:
Pharmacology his hthe hstudy hof hdrugs hand htheir haction hon hliving horganisms.
hThus, han hessential haspect hof hpharmacology his hdrug haction. hAn hunderstanding
hof hthe hdrug hname,hdrug hclass, hand hdrug hsource his himportant, hbut hthe hmost
hcritical haspect hrelated hto hpharmacology his hhow hthe hdrug hacts hin hthe hbody.
2. A hnursing hstudent his hpreparing hto hadminister ha hprescribed hdrug hto ha hpatient. hThe
hstudent hreviews hinformation habout hthe hdrug hand hits hactions. hWhich hof hthe
hfollowing hwould hbe hthehbest hchoice hfor hobtaining hthis hinformation? hSelect hall hthat
happly.
A) Nursing hinstructor
B) Nurse hassigned hto hthe hpatient
C) Clinical hdrug hreference
D) Prescribing hhealth hcare hprovider
E) Clinical
hpharmacisthAns: h C, hE
Feedback:
Although hthe hnursing hstudent hcan hask hthe hnursing hinstructor, hthe hnurse hassigned
hto hthe hpatient, hand hthe hprescribing hhealth hcare hprovider hfor hinformation habout
hthe hdrug, hthe hbesthchoices hfor hdrug hinformation hwould hinclude han happropriate
hdrug hreference hand hthe hclinical hpharmacist.
3. When hdescribing hthe hvarious htypes hof hmedications hto ha hgroup hof hnursing
hstudents, hahnursing hinstructor hwould hidentify hwhich hof hthe hfollowing has ha
hsource hfor hderiving hmedications? hSelect hall hthat happly.
A) Plants
B) Synthetic hsources
C) Mold
D) Minerals
E) Animals
hAns: hA, hB, hC,
hD, hEhFeedback:
Medications hare hderived hfrom hnatural hsources, hfor hexample, hplants, hmolds,
hminerals, handhanimals, has hwell has hcreated hsynthetically hin ha hlaboratory.
Page h 2
,4. Which hof hthe hfollowing hnames hmay hbe hassigned hto ha hdrug hduring hthe
hprocess hofhdevelopment? hSelect hall hthat happly.
A) Chemical hname
B) Official hname
C) Pharmacologic hname
D) Trade hname
E) Nonproprietary
hnamehAns: h A, hB, hD, hE
hFeedback:
Throughout hthe hprocess hof hdevelopment, hdrugs hmay hhave hseveral hnames hassigned
hto hthem hincluding ha hchemical hname, ha hgeneric h(nonproprietary) hname, han hofficial
hname, handha htrade hor hbrand hname.
5. A hdrug hmay hbe hclassified hby hwhich hof hthe hfollowing? hSelect hall hthat happly.
A) The hchemical htype hof hthe hdrug's hactive hingredient
B) The hway hthe hdrug his hused hto htreat ha hspecific hcondition
C) The hgeneric hname hof hthe hdrug
D) The htrade hname hof hthe hdrug
E) The hnonproprietary hname hof hthe
hdrughAns: h A, hB
Feedback:
A hdrug hmay hbe hclassified hby hthe hchemical htype hof hthe hactive hingredient hor hby hthe
hway hit hishused hto htreat ha hparticular hcondition. hGeneric, htrade, hand hnonproprietary
hrefer hto hhow ha hdrug his hnamed.
6. A hgroup hof hnursing hstudents hare hreviewing hinformation habout hthe hprocess hof
hdrug hdevelopment hin hthe hUnited hStates. hThe hstudents hdemonstrate
hunderstanding hof hthis hprocess hwhen hthey hidentify hthat hwhich hof hthe hfollowing
hcategories hare hassigned hby hthehFood hand hDrug hAdministration hto hnewly
happroved hdrugs? hSelect hall hthat happly.
A) Metabolite
B) Noncontrolled hsubstance
C) Prescription
D) Nonprescription
E) Controlled
hsubstancehAns: h C, hD, hE
Feedback:
Once hdrugs hare happroved hfor huse, hthe hFDA hassigns hthe hdrug hto hone hof hthe
hfollowing hcategories: hprescription, hnonprescription, hor hcontrolled hsubstance.
hMetabolite hrefers htohthe hinactive hform hof hthe hdrug. hNoncontrolled hsubstance his
ha hterm hthat his hnot hused.
Page h 3
, 7. Which hof hthe hfollowing hwould hbe hmost himportant hfor hthe hnurse hto hdo hto
hensure hthe hsafehuse hof hprescription hdrugs hin hthe hinstitutional hsetting? hSelect hall
hthat happly.
A) Administering hdrugs
B) Monitoring hclients hfor hdrug heffects
C) Prescribing hdrugs
D) Evaluating hclients hfor htoxic heffects
E) Educating hclients/caregivers habout
hdrugshAns: h A, hB, hD, hE
Feedback:
In hthe hinstitutional hsetting, hthe hnurse's hrole hto hensure hsafe huse hof hprescription
hdrugs hincludes hadministering hdrugs, hmonitoring hdrug heffects, hevaluating hfor htoxic
heffects, handheducating hclients hand hcaregivers habout hdrugs.
8. The hnurse his hhelping ha hclient hreview ha hprescription hfrom hthe hhealth hcare
hprovider. hWhenhexamining hthe hprescription, hwhich hof hthe hfollowing hwould hthe
hnurse hexpect hto hfind hdocumented? hSelect hall hthat happly.
A) Name hof hthe hdrug
B) Dosage hof hthe hdrug
C) Route hof hdrug hadministration
D) Times hof hdrug hadministration
E) Licensed hprescriber's
hsignaturehAns: h A, hB, hC, hD, hE
Feedback:
The hprescription hmust hcontain hthe hclient's hname, hthe hname hof hthe hdrug, hthe
hdosage, hthehmethod hand htimes hof hadministration, hand hthe hsignature hof hthe
hlicensed hhealth hcare hprovider hprescribing hthe hdrug.
9. After hteaching ha hgroup hof hnursing hstudents habout hnonprescription hdrugs, hthe
hnursing hinstructor hdetermines hthat hthe hteaching hwas hsuccessful hwhen hthe hstudents
hidentify hwhichhof hthe hfollowing? hSelect hall hthat happly.
A) They hrequire ha hlicensed hhealth hcare hprovider's hsignature.
B) They hare hreferred hto has hover-the-counter hdrugs.
C) They hcan hbe htaken hwithout hrisk hto hthe hclient.
D) They hhave hcertain hlabeling hrequirements.
E) They hshould hbe htaken honly has hdirected hon hthe
hlabel.hAns: h B, hD, hE
Feedback:
Nonprescription hdrugs hare hoften hreferred hto has hover-the-counter h(OTC) hdrugs.
hThey hdo hnot hrequire ha hprescription h(a hlicensed hhealth hcare hprovider's hsignature)
hbut hdo hnot hcome hwithout hrisk hto hthe hclient. hThe hfederal hgovernment hhas
himposed hlabeling hrequirements hofhOTC hdrugs hand hthey hshould honly hbe htaken has
hdirected hon hthe hlabel hunless hunder hthe hsupervision hof ha hhealth hcare hprovider.
Page h 4
